Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)

Published:2009-05-20 Issue:15_suppl Volume:27 Page:CRA8000-CRA8000
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Belani C. P.¹,Brodowicz T.¹,Ciuleanu T.¹,Kim J. H.¹,Krzakowski M.¹,Laack E.¹,Wu Y. L.¹,Peterson P.¹,Krejcy K.¹,Zielinski C.¹

Affiliation:

1. Penn State Hershey Cancer Institute, Hershey, PA; Medical University Vienna General Hospital and CECOG, Vienna, Austria; Oncology Institute Ion Chiricuta and CECOG, Cluj, Romania; Yonsei Cancer Center, Seoul, Republic of Korea; Centre of Oncology-Institute and CECOG, Warsaw, Poland; University Cancer Center Hamburg, Eppendorf, Germany; Guangdong Province People's Hospital, Guangzhou, China; Eli Lilly and Company, Indianapolis, IN; Eli Lilly Regional Operations, Vienna, Austria; Medical University of...

Abstract

CRA8000 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. [Table: see text]

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Point sur les cancers du poumon en 2010;Bulletin du Cancer;2010-01

2. Review: Advanced non-small cell lung cancer: the role of maintenance therapy;Therapeutic Advances in Medical Oncology;2009-12-08